Caspase-dependent cleavage of nucleic acids

Cell Death and Differentiation

Volumn 7, Issue 7, 2000, Pages 616-627

  Degen, W G J ^a   Pruijn, G J M ^a   Raats, J M H ^a   Van Venrooij, W J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; Autoantigen; CAD; Caspase; Chromosomal DNA; ICAD

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CASPASE; DNA; MESSENGER RNA; NUCLEIC ACID; RIBOSOME RNA; SMALL NUCLEAR RNA;

APOPTOSIS; AUTOIMMUNE DISEASE; DNA CLEAVAGE; NUCLEIC ACID METABOLISM; PRIORITY JOURNAL; REVIEW; RNA CLEAVAGE;

EID: 0033922731     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400672     Document Type: Review

References (85)

1. Craft J and Fatenejad S (1997) Self antigens and epitope spreading in systemic autoimmunity. Arthritis Rheum. 40: 1374-1382
2. McCluskey J, Farris AD, Keech CL, Purcell AW, Rischmueller M, Kinoshita G, Reynolds P and Gordon TP (1998) Determinant spreading: lessons from animal models and human disease. Immunol. Rev. 164: 209-229
3. Vaishnaw AK, McNally JD and Elkon KB (1997) Apoptosis in the rheumatic diseases. Arthritis Rheum. 40: 1917-1927
4. Rosen A and Casciola-Rosen LA (1999) Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ. 6: 6-12
5. Casciola-Rosen LA, Anhalt GJ and Rosen A (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179: 1317-1330
6. Casciola-Rosen LA, Anhalt GJ and Rosen A (1995) DMA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J. Exp. Med. 182: 1625-1634
7. Casciola-Rosen LA, Rosen A, Petri M and Schlissel M (1996) Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 93: 1624-1629
8. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB and Kalden JR (1998) Impaired phagocytosis of apoptotic cell material by rnonocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 41: 1241-1250
9. Emlen W, Niebur J and Kadera R (1994) Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J. Immunol 152: 3685-3692
10. Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ and Bell AL (1999) Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann. Rheum. Dis. 58: 309-314
11. Cohen GM (1997) Caspases: the executioners of apoptosis. Biochem. J., 326: 1-16
12. Utz PJ and Anderson P (1998) Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum. 41: 1152-1160
13. Andrade F, Roy S, Nicholson D, Thornberry N, Rosen A and Casciola-Rosen LA (1998) Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity 8: 451-460
14. Casciola-Rosen LA, Andrade F, Ulanet D, Wong WB and Rosen A (1999) Cleavage by granzyme B is strongly predictive of auloantigen status: Implications for initiation of autoimmunity. J. Exp. Med. 190: 815-825
15. Shi L, Kam CM, Powers JC, Aebersold R and Greenberg AH (1992) Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J. Exp. Med. 176: 1521-1529
16. Shresta S, Macivor DM, Heusel JW, Russell JH and Ley TJ (1995) Natural killer and lymphokine-activated killercells require granzyme B for the rapid induction of apoptosis in susceptible target cells. Proc. Natl. Acad. Sci. USA 92: 5679-5683
17. Heusel JW, Wesselschmidt RL, Shresta S, Russell JH and Ley TJ (1994) Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76: 977-987
18. Utz PJ, Horttelet M, van Venrooij WJ and Anderson P (1998) Association of phosphorylated serine/arginine (SR) splicing factors with the U1-small ribonucleoprotein (snRNP) autoantigen complex accomparies apoptotic cell death. J. Exp. Med. 187: 547-560
19. Rutjes SA, Utz PJ, Broekhuis C, van der Heijden A, van Venrooij WJ and Pruijn GJ (1999) The La (SS-B) autoantigen, a key protein in RNA biogenesis, is dephosphorylated and cleaved early during apoptosis. Cell Death Differ. 6:976-986
20. Piacentini M and Colizzi V (1999) Tissue transglutaminase: apoptosis versus autoimmunity. Immunol. Today 20: 130-134
21. Marushige Y and Marushige K (1995) Disappearance of ubiquitinated histone H2A during chromatin condensation in TGF beta 1-induced apoptosis. Anticancer Res. 15: 267-272
22. Asaga H, Yamada M and Senshu T (1998) Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages. Biochem. Biophys. Res. Commun. 243: 641-646
23. Rumore PM and Steinman CR (1990) Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. J. Clin. Invest. 86: 69-74
24. Rumore PM, Muralidhar B, Lin M, Lai C and Steinman CR (1992) Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance. Clin. Exp. Immunol. 90: 56-62
25. Losman MJ, Fasy TM, Novick KE and Monestier M (1992) Monoclonal autoantibodies to subnucleosomes from a MRL/Mp(-)+/+ mouse. Oligoclonality of the antibody response and recognition of a determinant composed of histones H2A, H2B, and DNA. J. Immunol. 148: 1561-1569
26. Tax WJ, Kramers C, van-Bruggen MC and Berden JH (1995) Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus. Kidney Int. 48: 666-673
27. Kerr JF, Wyllie AH and Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26: 239-257
28. Wyllie AH, Kerr JF and Currie AR (1980) Cell death: the significance of apoptosis. Int. Rev. Cytol. 68: 251-306
29. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A and Nagata S (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391: 43-50
30. Sakahira H, Enari M and Nagata S (1998) Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391: 96-99
31. Liu X, Li P, Widlak P, Zou H, Luo X, Garrard WT and Wang X (1998) The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proc. Natl. Acad. Sci. USA 95: 8461-8466
32. Liu X, Zou H, Slaughter C and Wang X (1997) DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89: 175-184
33. Halenbeck R, MacDonald H, Roulston A, Chen TT, Conroy L and Williams LT (1998) CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45. Curr. Biol. 8: 537-540
34. Mukae N, Enari M, Sakahira H, Fukuda Y, Inazawa J. Toh H and Nagata S (1998) Molecular cloning and characterization of human caspase-activated DNase. Proc. Natl. Acad. Sci. USA 95: 9123-9128
35. Tang D and Kidd VJ (1998) Cleavage of DFF-45/ICAD by multiple caspases is essential for its function during apoptosis. J. Biol. Chem. 273: 28549-28552
36. Liu X, Zou H, Widlak P, Garrard W and Wang X (1999) Activation of the apoptotic endonuclease DFF40 (caspase-activated DNase or nuclease). Oligomerization and direct interaction with histone H1. J. Biol. Chem. 274: 13836-13840
37. McCarty JS, Toh SY and Li P (1999) Study of DFF45 in its role of chaperone and inhibitor: Two independent inhibitory domains of DFF40 nuclease activity. Biochem. Biophys. Res. Commun. 264: 176-180
38. McCarty JS, Toh SH and Li P (1999) Multiple domains of DFF45 bind synergistically to DFF40: Roles of caspase cleavage and sequestration of activator domain of DFF40. Biochem. Biophys. Res. Commun. 264: 181-185
39. Gu J, Dong RP, Zhang C, McLaughlin DF, Wu MX and Schlossman SF (1999) Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40. J. Biol. Chem. 274: 20759-20762
40. Inohara N, Koseki T, Chen S, Benedict MA and Nunez G (1999) Identification of regulatory and catalytic domains in the apoptosis nuclease DFF40/CAD. J. Biol. Chem. 274: 270-274
41. Inohara N, Koseki T, Chen S, Wu X and Nunez G (1998) CIDE, a novel family of cell death activators with homology to the 45 kDa subunit of the DNA fragmentation factor. EMBO J. 17: 2526-2533
42. Toh SY, Wang XD and Li P (1998) Identification of the nuclear factor HMG2 as an activator for DFF nuclease activity. Biochem. Biophys. Res. Commun. 250: 598-601
43. Sakahira H, Enari M, Ohsawa Y, Uchiyama Y and Nagata S (1999) Apoptotic nuclear morphological change without DNA fragmentation. Curr. Biol. 9: 543-546
44. Sahara S, Aoto M, Eguchi Y, Imamoto N, Yoneda Y and Tsujimoto Y (1999) Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation. Nature 401: 168-173
45. Elkon KB, Parnassa AP and Foster CL (1985) Lupus autoantibodies target ribosomal P proteins. J. Exp. Med. 162: 459-471
46. Uchiumi T, Wahba AJ and Traut RR (1987) Topography and stoichiometry of acidic proteins in large ribosomal subunits from Artemia salina as determined by crosslinking. Proc. Natl. Acad. Sci. USA 84: 5580-5584
47. Uchiumi T and Kominami R (1992) Direct evidence for interaction of the conserved GTPase domain with 28 S RNA with mammalian ribosomal acidic phosphoproteins and L12. J. Biol. Chem. 267: 19179-19185
48. Uchiumi T, Traut RR, Elkon K and Kominami R (1991) A human autoantibody specific for a unique conserved region of 28 S ribosomal RNA inhibits the interaction of elongation factors 1 alpha and 2 with ribosomes. J. Biol. Chem. 266: 2054-2062
49. Chu JL, Brot N, Weissbach H and Elkon K (1991) Lupus antiribosomal P antisera contain antibodies to a small fragment of 28S rRNA located in the proposed ribosomal GTPase center. J. Exp. Med. 174: 507-514
50. Bonfa E, Parnassa AP, Rhoads DD, Roufa DJ, Wool IG and Elkon KB (1989) Antiribosomal S10 antibodies in humans and MRL/lpr mice with systemic lupus erythematosus. Arthritis Rheum. 32: 1252-1261
51. Sato T, Uchiumi T, Kominami R and Arakawa M (1990) Autoantibodies specific for the 20-KDa ribosomal large subunit protein L12. Biochem. Biophys. Res. Commun. 172: 496-502
52. von Mikecz A, Hemmerich P, Peter HH and Krawinkel U (1994) Characterization of eukaryotic protein L7 as a novel autoantigen which frequently elicits an immune response in patients suffering from systemic autoimmune disease. Immunobiology 192: 137-154
53. Michot B, Hassouna N and Bachellerie JP (1984) Secondary structure of mouse 28S rRNA and general model for the folding of the large rRNA in eukaryotes. Nucleic Acids Res. 12: 4259-4279
54. Raue HA, Klootwijk J and Musters W (1988) Evolutionary conservation of structure and function of high molecular weight ribosomal RNA. Prog. Biophys. Mol. Biol. 51: 77-129
55. Michot B and Bachellerie JP (1987) Comparisons of large subunit rRNAs reveal some eukaryote-specific elements of secondary structure. Biochimie 69: 11-23
56. Gutell RR and Fox GE (1988) A compilation of large subunit RNA sequences presented in a structural format. Nucleic Acids Res. 16 (Suppl): r175-r269
57. Gonzalez IL, Gorski JL, Campen TJ, Dorney DJ, Erickson JM, Sylvester JE and Schmickel RD (1985) Variation among human 28S ribosomal RNA genes. Proc. Natl. Acad. Sci. USA 82: 7666-7670
58. Houge G and Doskeland SO (1996) Divergence towards a dead end? Cleavage of the divergent domains of ribosomal RNA in apoptosis. Experientia 52: 963-967
59. Houge G, Doskeland SO, Boe R and Lanotte M (1993) Selective cleavage of 28S rRNA variable regions V3 and V13 in myeloid leukemia cell apoptosis. FEBS Lett. 315: 16-20
60. Casiano CA, Martin SJ, Green DR and Tan EM (1996) Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1 (-mediated T cell apoptosis. J. Exp. Med. 184: 765-770
61. Houge G, Robaye B, Eikhom TS, Golstein J, Mellgren G, Gjertsen BT, Lanotte M and Doskeland SO (1995) Fine mapping of 28S rRNA sites specifically cleaved in cells undergoing apoptosis. Mol. Cell Biol. 15: 2051-2062
62. Samali A, Gilje B, Doskeland SO, Cotter TG and Houge G (1997) The ability to cleave 28S ribosomal RNA during apoptosis is a cell-dependent trait unrelated to DNA fragmentation. Cell Death Differ. 4: 289-293
63. Lafarga M, Lerga A, Andres MA, Polanco JI, Calle E and Berciano MT (1997) Apoptosis induced by methylazoxymethanol in developing rat cerebellum: organization of the cell nucleus and its relationship to DNA and rRNA degradation. Cell Tissue Res. 289: 25-38
64. Crawford DR, Lauzon RJ, Wang Y, Mazurkiewicz JE, Schools GP and Davies KJ (1997) 16S mitochondrial ribosomal RNA degradation is associated with apoptosis. Free Radic. Biol. Med. 22: 1295-1300
65. Mondino A and Jenkins MK (1995) Accumulation of sequence-specific RNA-binding proteins in the cytosol of activated T cells undergoing RNA degradation and apoptosis. J. Biol. Chem. 270: 26593-26601
66. Owens GP and Cohen JJ (1992) Identification of genes involved in programmed cell death. Cancer Metastasis Rev. 11: 149-156
67. Sharp PA (1994) Split genes and RNA splicing. Cell 77: 805-815
68. Klein Gunnewiek JM, van de Putte LB and van Venrooij WJ (1997) The U1 snRNP complex: an autoantigen in connective tissue diseases. An update. Clin. Exp. Rheumatol. 15: 549-560
69. Casciola-Rosen LA, Miller DK, Anhalt GJ and Rosen A (1994) Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J. Biol. Chem. 269: 30757-30760
70. Casciola-Rosen LA, Nicholson DW, Chong T, Rowan KR, Thornberry NA, Miller DK and Rosen A (1996) Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J. Exp. Med. 183: 1957-1964
71. Degen WGJ, van Aarssen Y, Pruijn GJM, Utz PJ and van Venrooij WJ (2000) The fate of U1 snRNP during anti-Fas induced apoptosis: specific cleavage of the U1 snRNA molecule. Cell Death Differ. 7: 70-80
72. van Venrooij WJ, Hoet R, Castrop J, Hageman B, Mattaj IW and van de Putte LB (1990) Anti-(U1) small nuclear RNA antibodies in anti-small nuclear ribonucleoprotein sera from patients with connective tissue diseases. J. Clin. Invest. 86: 2154-2160
73. Hoet RMA, Koornneef I, de Rooij DJ, van de Putte LB and van Venrooij WJ (1992) Changes in anti-U1 RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndrome. Arthritis Rheum. 35: 1202-1210
74. Hoet RMA, De Weerd P, Klein Gunnewiek J, Koornneef I and van Venrooij WJ (1992) Epitope regions on U1 small nuclear RNA recognized by anti-U1RNA-specific autoantibodies. J. Clin. Invest. 90: 1753-1762
75. Teunissen SW, Stassen MH, Pruijn GJ, van Venrooij WJ and Hoet RM (1998) Characterization of an anti-RNA recombinant autoantibody fragment (scFv) isolatedfrom a phage display library and detailed analysis of its binding site on U1 snRNA. RNA 4: 1124-1133
76. Hoet RMA, Pieffers M, Stassen MH, Raats JMH, de Wildt R, Pruijn GJM, van den Hoogen F and van Venrooij WJ (1999) The importance of the light chain for the epitope specificity of human anti-U1 small nuclear RNA autoantibodies present in systemic lupus erythematosus patients. J. Immunol. 163: 3304-3312
77. Massenet S, Mougin A and Branlant C (1998) Posttranscriptional modifications in the U small nuclear RNAs. In Modification and editing of RNA. Grosjean H and Benne R eds, (ASM Press) pp. 201-227
78. Tan EM (1989) Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44: 93-152
79. van Venrooij WJ, Slobbe RL and Pruijn GJ (1993) Structure and function of La and Ro RNPs. Mol. Biol. Rep. 18: 113-119
80. Boulanger C, Chabot B, Menard HA and Boire G (1995) Autoantibodies in human anti-Ro sera specifically recognize deproteinized hY5 Ro RNA. Clin. Exp. Immunol. 99: 29-36
81. Rutjes SA, van der Heijden A, Utz PJ, van Venrooij WJ and Pruijn GJ (1999) Rapid nucleolytic degradation of the small cytoplasmic Y RN As during apoptosis. J. Biol. Chem. 274: 24799-24807
82. Temsamani J, Agrawal S and Pederson T (1991) Biotinylated antisense methylphosphonateoligodeoxynucleotides. Inhibition of spliceosome assembly and affinity selection of U1 and U2 small nuclear RNPs. J. Biol. Chem. 266: 468-472
83. Crispino JD, Blencowe BJ and Sharp PA (1994) Complementation by SR proteins of pre-mRNA splicing reactions depleted of U1 snRNP. Science 265: 1866-1869
84. Jiang ZH, Zhang WJ, Rao Y and Wu JY (1998) Regulation of lch-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors. Proc. Natl. Acad. Sci. USA 95: 9155-9160
85. Pellizzoni L, Lotti F, Rutjes SA and Pierandrei AP (1998) Involvement of the Xenopus laevis Ro60 autoantigen in the alternative interaction of La and CNBP proteins with the 5′ UTR of L4 ribosomal protein mRNA. J. Mol. Biol. 281: 593-608